Developing a New Class of Engineered Live Bacterial Therapeutics to Treat Human Diseases

Nature Communications - United Kingdom
doi 10.1038/s41467-020-15508-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Nuclease-Resistant Synthetic Ribozymes: Developing a New Class of Therapeutics

Journal of Clinical Investigation
Medicine
2000English

A New Drug to Treat Prion Diseases

Lab Animal
Animal ScienceZoologyVeterinary
2019English

New Therapeutics to Treat Castrate-Resistant Prostate Cancer

The Scientific World Journal
BiochemistryMedicineGeneticsMolecular BiologyEnvironmental Science
2013English

Taurine Analogues: A New Class of Therapeutics

2012English

Advances in Developing Prophylactics and Therapeutics to Counter Inflammatory, Allergic and Infectious Diseases

Recent Patents on Inflammation and Allergy Drug Discovery
MedicineDrug DiscoveryAllergyImmunology
2018English

Genetically Engineered Pig Models for Human Diseases

Annual Review of Animal Biosciences
Animal ScienceZoologyVeterinaryGeneticsBiotechnology
2013English

New Therapeutics to Modulate Mitochondrial Dynamics and Mitophagy in Cardiac Diseases

Journal of Molecular Medicine
Molecular MedicineDrug DiscoveryGenetics
2015English

Semisynthetic Supra Plasma Expanders: A New Class of Therapeutics to Improve Microcircualtion in Sickle Cell Anaemia

Artificial Cells, Nanomedicine and Biotechnology
MedicineBiotechnologyBiomedical EngineeringPharmaceutical Science
2019English

Rare and Difficult to Treat Haematological Diseases

The Lancet Haematology
Hematology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy